Third-quarter revenues for CryoLife increased 5 percent over the same period last year, to a quarterly record of $28.2 million, according to a release from the company.
The company also reported that revenues for the first nine months of 2009 increased 4 percent over the same period last year, to a record $83.1 million.
Cryolife is an implantable biological medical device and cardiovascular tissue processing company.
Read Crylife’s release on third-quarter revenues.
From findings on cervical disc replacement to total knee replacement, Becker’s reported on eight spine and orthopedic studies since March…
Researchers at UMass Chan Medical School in Worcester, Mass., have created an algorithm to predict total knee replacement outcomes in…
Orthopaedic Solutions Management has acquired Orlando Hand Surgical Associates, marking its eighth acquisition. OHSA was founded in 2000 and has…
Comments are closed.